Literature DB >> 29668248

Systematic Study in Mammalian Cells Showing No Adverse Response to Tetrahedral DNA Nanostructure.

Kai Xia1, Huating Kong, Yunzhi Cui1, Ning Ren1, Qingnuan Li, Jifei Ma, Rongrong Cui, Yu Zhang, Jiye Shi2, Qian Li, Min Lv, Yanhong Sun, Lihua Wang, Jiang Li, Ying Zhu.   

Abstract

The advent of DNA technology has demonstrated great potential in a wide range of applications, especially in the field of biology and biomedicine. However, current understanding of the toxicological effects and cellular responses of DNA nanostructures remains to be improved. Here, we chose tetrahedral DNA nanostructures (TDNs), a type of nanocarriers for delivering molecular drugs, as a model for systematic live-cell analysis of the biocompatibility of TDNs to normal bronchial epithelial cells, carcinoma cells, and macrophage. We found that the interaction behaviors of TDNs in different cell lines were very different, whereas after internalization, most of the TDNs in diverse cell lines were positioned to lysosomes. By a systematic assessment of cell responses after TDN exposure to various cells, we demonstrate that internalized TDNs have good innate biocompatibility. Interestingly, we found that TDN-bearing cells would not affect the cell cycle progression and accompany cell division and that TDNs were separated equally into two daughter cells. This study improves our understanding of the interaction of DNA nanostructures with living systems and their biocompatibility, which will be helpful for further designing DNA nanostructures for biomedical applications.

Entities:  

Keywords:  biocompatibility; cell; cell cycle; interaction; tetrahedral DNA nanostructures (TDNs)

Mesh:

Substances:

Year:  2018        PMID: 29668248     DOI: 10.1021/acsami.8b02626

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  7 in total

1.  Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment.

Authors:  Tao Zhang; Taoran Tian; Ronghui Zhou; Songhang Li; Wenjuan Ma; Yuxin Zhang; Nanxin Liu; Sirong Shi; Qianshun Li; Xueping Xie; Yichen Ge; Mengting Liu; Qi Zhang; Shiyu Lin; Xiaoxiao Cai; Yunfeng Lin
Journal:  Nat Protoc       Date:  2020-07-15       Impact factor: 13.491

Review 2.  The Growing Development of DNA Nanostructures for Potential Healthcare-Related Applications.

Authors:  Divita Mathur; Igor L Medintz
Journal:  Adv Healthc Mater       Date:  2019-03-07       Impact factor: 11.092

3.  MicroRNA-214-3p modified tetrahedral framework nucleic acids target survivin to induce tumour cell apoptosis.

Authors:  Songhang Li; Yue Sun; Taoran Tian; Xin Qin; Shiyu Lin; Tao Zhang; Qi Zhang; Mi Zhou; Xiaolin Zhang; Yi Zhou; Hu Zhao; Bofeng Zhu; Xiaoxiao Cai
Journal:  Cell Prolif       Date:  2019-10-23       Impact factor: 6.831

Review 4.  Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy.

Authors:  Ratchanee Duangrat; Anuttara Udomprasert; Thaned Kangsamaksin
Journal:  Cancer Sci       Date:  2020-07-20       Impact factor: 6.716

Review 5.  Pharmaceutical applications of framework nucleic acids.

Authors:  Liang Chen; Jie Zhang; Zhun Lin; Ziyan Zhang; Miao Mao; Jiacheng Wu; Qian Li; Yuanqing Zhang; Chunhai Fan
Journal:  Acta Pharm Sin B       Date:  2021-05-26       Impact factor: 11.413

Review 6.  The biological applications of DNA nanomaterials: current challenges and future directions.

Authors:  Wenjuan Ma; Yuxi Zhan; Yuxin Zhang; Chenchen Mao; Xueping Xie; Yunfeng Lin
Journal:  Signal Transduct Target Ther       Date:  2021-10-08

Review 7.  DNA Nanodevice-Based Drug Delivery Systems.

Authors:  Chaoyang Guan; Xiaoli Zhu; Chang Feng
Journal:  Biomolecules       Date:  2021-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.